Yuan Sui

Yuan Sui

Auto-generated profile, based on publicly available information

Yuan Sui

Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2023 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YSYuan Sui
Yuan Sui
SLShuping Li
Shuping Li
XFXue-qi Fu
Xue-qi Fu
ZZZhizhuang Zhao
Zhizhuang Zhao
SXShu Xing
Shu Xing
Background: Inadequate immunity caused by poor immune surveillance leads to tumorigenesis, while excessive immunity due to breakdown of immune tolerance causes autoimmune genesis. Although the function of immunity during the onset of these two processes appears to be distinct, the underlying mechanism is shared. To date, gene expression data for large bodies of clinical samples are available, but the resemblances of tumorigenesis and autoimmune genesis in terms of immune responses remains to be summed up.Methods: Considering the high disease prevalence, we chose invasive ductal carcinoma (IDC) and systemic lupus erythematosus (SLE) to study the potential commonalities of immune responses. We obtained gene expression data of IDC/SLE patients and normal controls from five IDC databases (GSE29044, GSE21422, GSE22840, GSE15852, and GSE9309) and five SLE databases (GSE154851, GSE99967, GSE61635, GSE50635, and GSE17755). We intended to identify genes differentially expressed in both IDC and SLE by using three bioinformatics tools including GEO2R, the limma R package, and Weighted Gene Co-expression Network Analysis (WGCNA) to perform function enrichment, protein-protein network, and signaling pathway analyses.Results: The mRNA levels of signal transducer and activator of transcription 1 (STAT1), 2'-5'-oligoadenylate synthetase 1 (OAS1), 2'-5'-oligoadenylate synthetase like (OASL), and PML nuclear body scaffold (PML) were found to be differentially expressed in both IDC and SLE by using three different bioinformatics tools of GEO2R, the limma R package and WGCNA. From the combined databases in this study, the mRNA levels of STAT1 and OAS1 were increased in IDC while reduced in SLE. And the mRNA levels of OASL and PML were elevated in both IDC and SLE. Based on Kyoto Encyclopedia of Genes and Genomes pathway analysis and QIAGEN Ingenuity Pathway Analysis, both IDC and SLE were correlated with the changes of multiple components involved in the Interferon (IFN)-Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway.Conclusion: The expression levels of STAT1 and OAS1 manifest the opposite expression tendency across cancer and autoimmune disease. They are components in the IFN-JAK-STAT signaling pathway related to both tumorigenesis and autoimmune genesis. STAT1 and OAS1-associated IFN-JAK-STAT signaling could explain the commonalities during tumorigenesis and autoimmune genesis and render significant information for more precise treatment from the point of immune homeostasis.

15 April 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
XMXiaobing Ming
Xiaobing Ming
Yong WangYong Wang
Yong Wang
YSYuan Sui
Yuan Sui
The effect of exogenous mannitol and sorbitol on the viability of the antagonist yeast, Debaryomyces hansenii, when exposed to oxidative and high-temperature stress was determined. Results indicated that both the 0.1 M mannitol (MT) and 0.1 M sorbitol (ST) treatments improved the tolerance of D. hansenii to subsequent oxidative and high-temperature stress. MT or ST cells had a significantly higher level of cell survival, elevated the gene expression of catalase 1 (CAT1) and copper-zinc superoxide dismutase (SOD1), as well as the corresponding enzyme activity. Treated cells also exhibited a lower accumulation of intracellular reactive oxygen species (ROS), and a higher content of intracellular mannitol and sorbitol relative to non-treated, control yeast cells, when exposed to a subsequent oxidative (30 mM H2O2) or heat (40.5°C) stress for 30 min. Additionally, MT and ST yeast exhibited a higher growth rate in kiwifruit wounds, and a greater ability to inhibit postharvest blue mold (Penicillium expansum) and gray mold (Botrytis cinerea) infections. The present study indicates that increased antioxidant response induced by mannitol and sorbitol in D. hansenii can enhance stress tolerance and biocontrol performance.

23 October 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
RGRuicai Gu
Ruicai Gu
TKTae-Dong Kim
Tae-Dong Kim
HSHoogeun Song
Hoogeun Song
YSYuan Sui
Yuan Sui
SSSook Shin
Sook Shin
RJRalf Janknecht
Ralf Janknecht
The histone demethylase JMJD2A/KDM4A facilitates prostate cancer development, yet how JMJD2A function is regulated has remained elusive. Here, we demonstrate that SET7/9-mediated methylation on 6 lysine residues modulated JMJD2A. Joint mutation of these lysine residues suppressed JMJD2A’s ability to stimulate the MMP1 matrix metallopeptidase promoter upon recruitment by the ETV1 transcription factor. Mutation of just 3 methylation sites (K505, K506, and K507) to arginine residues (3xR mutation) was sufficient to maximally reduce JMJD2A transcriptional activity and also decreased its binding to ETV1. Introduction of the 3xR mutation into DU145 prostate cancer cells reduced in vitro growth and invasion and also severely compromised tumorigenesis. Consistently, the 3xR genotype caused transcriptome changes related to cell proliferation and invasion pathways, including downregulation of MMP1 and the NPM3 nucleophosmin/nucleoplasmin gene. NPM3 downregulation phenocopied and its overexpression rescued, to a large degree, the 3xR mutation in DU145 cells, suggesting that NPM3 was a seminal downstream effector of methylated JMJD2A. Moreover, we found that NPM3 was overexpressed in prostate cancer and might be indicative of disease aggressiveness. SET7/9-mediated lysine methylation of JMJD2A may aggravate prostate tumorigenesis in a manner dependent on NPM3, implying that the SET7/9→JMJD2A→NPM3 axis could be targeted for therapy.

14 January 2025 in Cancer Discovery
Verified
Journal Article
Closed access
XWXue Wang
Xue Wang
DLDerrick Lee
Derrick Lee
HXHaibo Xu
Haibo Xu
YSYuan Sui
Yuan Sui
JMJill Meisenhelder
Jill Meisenhelder
THTony Hunter
Tony Hunter
Identities of functional pSer-Thr.Pro protein substrates of the PIN1 prolyl isomerase and its effects on downstream signaling in bladder carcinogenesis remain largely unknown. Phenotypically, we found that PIN1 positively regulated bladder cancer cell proliferation, cell motility, and urothelium clearance capacity in vitro and controlled tumor growth and potential metastasis in vivo. Mechanistically, we observed a negative enrichment of SREBP2-driven cholesterol metabolism pathways and a decrease in free/total cholesterol levels in PIN1-knockout bladder cancer cells. Moreover, we showed that PIN1 interacted with SREBP2 following its phosphorylation by the JNK MAP kinase at Ser455, which lies near the site-2 cleavage site that generates the active, nuclear form of SREBP2. Therapeutically, a combination of the covalent PIN1 inhibitor sulfopin and the HMGCoA reductase inhibitor simvastatin synergistically suppressed cell proliferation in vitro and tumor growth in vivo. Together, these findings emphasize that PIN1 can act as a driver and potential therapeutic target in bladder cancer. Significance: This study provides deeper insights into the regulatory role of the phospho–dependent prolyl isomerase PIN1 in bladder cancer. The identification of the link between PIN1 and SREBP2-mediated transcription and cholesterol biosynthesis offers the potential for developing novel therapeutic strategies for bladder cancer.

6 April 2007 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
YSYuan Sui
Yuan Sui
JZJingbo Zhao
Jingbo Zhao
SGShenghua Gan
Shenghua Gan
HZHongchi Zhao
Hongchi Zhao
WYWantai Yang
Wantai Yang

1 February 2018 in Protein Expression and Purification
Verified
Journal Article
Closed access
YSYuan Sui
Yuan Sui
XFXingye Fu
Xingye Fu
YWYuchen Wang
Yuchen Wang
WHWeiyan Hu
Weiyan Hu
TZTong Zhang
Tong Zhang
XXXuesong Xu
Xuesong Xu